Carregant...
Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer
OBJECTIVE: To examine survival outcomes of women with recurrent cervical cancer who received salvage chemotherapy with modified dose-dense paclitaxel (MDDP) monotherapy (paclitaxel 80 mg/m(2), administered on day 1, 8, and 15 without day 22). MATERIALS AND METHODS: A retrospective study was conducte...
Guardat en:
| Publicat a: | Am J Clin Oncol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7528455/ https://ncbi.nlm.nih.gov/pubmed/28763329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000394 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|